Intravenous nicardipine is indicated for the treatment of acute life-threatening hypertension, particularly in the event of: Malignant arterial hypertension/Hypertensive encephalopathy; Aortic dissection, when short acting beta-blocker therapy is not suitable, or in combination with a beta-blocker when beta-blocking alone is not effective; Severe pre-eclampsia, when other intravenous antihypertensive agents are not recommended or are contra-indicated.
Nicardipine is also indicated for the treatment of post-operative hypertension.